Cart
sales@molnova.com
SK-575
CAS No. 2523016-96-6
SK-575( —— )
Catalog No. M36290 CAS No. 2523016-96-6
SK-575 is a degradation agent targeting protein-hydrolyzed PARP1 chimera with anticancer and antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 163 | Get Quote |
|
| 5MG | 250 | Get Quote |
|
| 10MG | 398 | Get Quote |
|
| 25MG | 799 | Get Quote |
|
| 50MG | 1279 | Get Quote |
|
| 100MG | 1971 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSK-575
-
NoteResearch use only, not for human use.
-
Brief DescriptionSK-575 is a degradation agent targeting protein-hydrolyzed PARP1 chimera with anticancer and antitumor activity.
-
DescriptionSK-575 is a highly potent and specific proteolysis-targeting chimera (PROTAC) degrader of PARP1, with an IC50 of 2.30 nM. SK-575 potently inhibits the growth of cancer cells bearing BRCA1/2 mutations.
-
In VitroWestern Blot AnalysisMCell Line:MDA-MB-436, Capan-1, and SW620 cells Concentration:10000, 1000, 300, 100, 30, 10, 3, 1, 0.3, 0.1, 0.03, and 0.01 nM Incubation Time:24 h Result:Showed good PARP1 degradation activity in these cancer cell lines (MDA-MB-436, Capan-1, and SW620 cells), with IC50 values of 1.26, 6.72 and 0.509 nM, respectively. Effectively induced the formation of γH2AX in MDA-MB-436 and Capan-1 cells in a dose dependent manner.
-
In VivoAnimal Model:Male BALB/c nude mice (bearing xenograft Capan-1 tumors)Dosage:25 mg/kg, 50 mg/kg Administration:IP, once daily for 5 consecutive days Result:Inhibited tumor growth. SK-575 at these doses (25 and 50 mg/kg) were well tolerated, with no mice lethality or significant weight loss observed during the treatment time.Animal Model:Female ICR mice (20-23 g, 6-7 week-old, n=3 per group) Dosage:25 mg/kg Administration: Intraperitoneally, a single dose (Pharmacokinetic Analysis)Result:Pharmacokinetic Parameters of SK-575 in female ICR mice.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2523016-96-6
-
Formula Weight876.97
-
Molecular FormulaC47H53FN8O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (114.03 mM; Ultrasonic )
-
SMILESO=C1NN=C(C=2C=CC=CC12)CC3=CC=C(F)C(=C3)C(=O)N4CCN(C(=O)CCCCCCCCCCC(=O)NCCNC5=CC=CC=6C(=O)N(C(=O)C56)C7C(=O)NC(=O)CC7)CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cao C, et al. Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers. J Med Chem. 2020 Oct 8;63(19):11012-11033.?
molnova catalog
related products
-
KSQ-4279
KSQ-4279 (USP1-IN-1) is an inhibitor of USP1 and PARP, exhibiting anticancer activity. It is utilized in the study of non-small cell lung cancer, osteosarcoma, ovarian, breast, glioblastoma, bladder, uterine, and pancreatic cancers.
-
Fluzoparib
fluzoparib is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.Fluzoparib potently inhibited PARP1 enzyme activity and induced DNA double-strand breaks, G2 /M arrest, and apoptosis in homologous recombination repair (HR)-deficient cells.?
-
AG-14361
AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides.
